Cargando…
Mycobacterium indicus pranii therapy induces tumor regression in MyD88- and TLR2-dependent manner
OBJECTIVES: Mycobacterium indicus pranii (MIP) is an atypical mycobacterium species with potent antitumor efficacy. Macrophages and dendritic cells (DCs) are antigen-presenting cells, playing key roles in the activation of antitumor immunity. We have previously shown the potent activation of macroph...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781299/ https://www.ncbi.nlm.nih.gov/pubmed/31590685 http://dx.doi.org/10.1186/s13104-019-4679-0 |